Core B: Large-Scale Cell Processing

$158,080P30FY2014DKNIH

Fred Hutchinson Cancer Research Center, Seattle WA

Investigators

Linked publications & trials

Paper 37903325 Paper 37774014 Paper 37379309 Paper 35303493 Paper 34666344 Paper 32967009 Paper 32721120 Paper 32076701 Paper 31748270 Paper 31605820 Paper 31419568 Paper 31133730 Paper 30940846 Paper 30782611 Paper 30728140 Paper 30520725 Paper 30279573 Paper 29625831 Paper 29588544 Paper 29554922 Paper 29421980 Paper 29243741 Paper 29025771 Paper 28924019 Paper 28715249 Paper 28677267 Paper 28119225 Paper 27762266 Paper 27751357 Paper 27668798 Paper 27605551 Paper 27570068 Paper 27430015 Paper 27248327 Paper 27197068 Paper 27058824 Paper 26733551 Paper 26673326 Paper 26355737 Paper 26320100 Paper 26053664 Paper 26052523 Paper 25996682 Paper 25983023 Paper 25965569 Paper 25965411 Paper 25875671 Paper 25852052 Paper 25708596 Paper 25648264 Paper 25408260 Paper 25343958 Paper 25317334 Paper 25275584 Paper 25267526 Paper 25237399 Paper 25237201 Paper 25105369 Paper 24937231 Paper 24913233 Paper 24794443 Paper 24704161 Paper 24642749 Paper 24525279 Paper 24513167 Paper 24462187 Paper 24451117 Paper 24395799 Paper 24371230 Paper 24358223 Paper 24287598 Paper 24278200 Paper 24240475 Paper 24141776 Paper 24131213 Paper 24076548 Paper 23994246 Paper 23959984 Paper 23953118 Paper 23952003 Paper 23913973 Paper 23799088 Paper 23798402 Paper 23752194 Paper 23723082 Paper 23719296 Paper 23690628 Paper 23666780 Paper 23661246 Paper 23651857 Paper 23624784 Paper 23620405 Paper 23604463 Paper 23602541 Paper 23587923 Paper 23576758 Paper 23520463 Paper 23510416 Paper 23471305 Paper 23466739

Abstract

Core B will support investigator-sponsored research by: (A) Standardizing procurement and optimizing processing, cryopreservation, storage, and distribution of cells from mobilized and nonmobilized peripheral blood, bone marrow, and cord blood, obtained from canine, primate, and human sources; (B) Enriching large numbers of hematopoietic stem/progenitor cells or other investigatorspecified cell populations, and providing high-quality cell populations to facilitate basic research and preclinical translational studies; (C) Extensive phenotyping, by multi-color flow cytometry, of clinical allogeneic transplant products and processed cells for correlative studies and characterization of processed cell fractions.

View original record on NIH RePORTER →